The impact of antipsychotic side effects on attitudes toward medication in patients with schizophrenia: A systematic review
|
|
- Polly Phillips
- 5 years ago
- Views:
Transcription
1 JBI Systematic Review Protocol The impact of antipsychotic side effects on attitudes toward medication in patients with schizophrenia: A systematic review Chiang Yan Ling 1, Piyanee Klainin 2, Jeanette Ignacio 3 1. Student, Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore National University Hospital (NUH) Centre for Evidence Based Nursing. u @nus.edu.sg. 2. Assistant Professor, Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore National University Hospital (NUH) Centre for Evidence Based Nursing. nurpk@nus.edu.sg. 3. Lecturer, Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore National University Hospital (NUH) Centre for Evidence Based Nursing. nurimjj@nus.edu.sg.
2 Background Schizophrenia is a serious, debilitating psychiatric disorder characterized by positive symptoms (namely hallucinations and delusions), negative symptoms (such as alogia, avolition, anhedonia, apathy and asociality), and disorganized symptoms (like disorganized speech and behaviour) 1. Antipsychotics have become the mainstay treatment 2,3 for symptomatic relief in both acute and chronic phases of schizophrenia, 4,5 and the maintenance of antipsychotic treatment has been shown to play a vital role in relapse prevention. 6,7 However, antipsychotics have long been associated with a wide range of side effects, 6,8 including anticholinergic, extrapyramidal, hormonal, cardiovascular and haematological reactions, and these potentially have an adverse effect on patients biological, psychological, sexual and social functioning. 3,8 Clinicians have frequently observed that some patients experience a changed subjective state barely after a few doses from the initiation of antipsychotic treatment. 9 This has been commonly described by patients as feeling apathetic, mummified, like zombies, and being incapable of thinking. 4 The development of undesirable side effects has shown to have many debilitating consequences, such as emotional distress, reduced quality of life, poorer interpersonal relationships, and reduced ability to undertake employment or fulfill work requirements. 3 Overall, many patients experience antipsychotics as unpleasant and something they would rather avoid. 2 As a result, medication noncompliance has become a major problem in antipsychotic treatment. 10,11 This has led to higher rates of relapse 5 and more frequent episodes of rehospitalisation. 12 The subsequent clinical course is usually poor, 13 with the exacerbations of symptoms eventually leading to the development of chronic psychosis. 14 Generally, it has become a challenge for patients to return to their pre-relapse level of social adjustment, fulfill social and familial roles, secure employment or reintegrate back into the society. 15 As such, medication compliance has become a focus of increasing concern for patients with schizophrenia, 2 However, there is a lack of an adequate methodology to directly assess medication compliance. Instead, some clinicians attempted to use other indirect but relatively more convenient methods of assessing medication compliance, and this has been done through examining a multitude of factors that appear to influence medication compliance. Among these, side effects and negative attitudes toward antipsychotics have emerged to be among the major predictors of medication noncompliance. 2,3,16,17 The importance of evaluating the patients perspective, especially their attitudes toward medication in the presence of side effects, has long been emphasised. 2,9,11,18 Hence, not only is it important to assess antipsychotic side effects independently, it is also essential to assess patients attitudes toward antipsychotics in relation to their experience of side effects. 4 However, no definite conclusion has been made thus far on the relationship between antipsychotic side effects and attitudes toward medication, as studies had conflicting results. There are studies that have found a positive relationship between antipsychotic side effects and negative attitudes toward medication, 4 with some of these relating negative attitudes toward medication to only specific individual side effects, such as sedation, 1 increased duration of sleep 19 and extrapyramidal symptoms. 5 However, there are a few studies that suggest a general weak relationship between antipsychotic side effects and negative attitudes toward medication. 3,19 2
3 This systematic review will therefore examine the impact of antipsychotic side effects on attitudes towards medication in patients with schizophrenia. The results from this review could provide insight on the relationship between antipsychotic side effects with patients attitudes toward medication. Unlike most of the other factors influencing medication noncompliance (such as demographic variables, psychopathology or insight), attitude is relatively modifiable, and its assessment allows for the potential implementation or intensification of more patient-centred, medication-directed interventions. This potentially increases patients acceptance of the necessity of pharmacological treatment 4, thereby promoting a more positive clinical course, better psychosocial functioning, formation of more stable and satisfactory social and family relationships, fewer symptoms and minimal episodes of rehospitalisation 3. Review Objective The objective of this systematic review is to systematically review the best available evidence to determine whether antipsychotic side effects have an impact on attitudes toward medication in patients with schizophrenia. More specifically, the review question is: What is the impact of antipsychotic side effects on attitudes toward medication in patients with schizophrenia? Criteria for Considering Studies for This Review Types of Studies This review will consider quantitative research papers that examine the magnitude of the effect of antipsychotic side effects on attitudes toward medication in patients with schizophrenia and report findings in quantifiable terms (such as effect sizes, correlation coefficients, or regression coefficient. The higest priority will be placed on studies with the highest level of evidence (such as randomised controlled trial and other experimental designs). Non-experimental studies, cohort studies, casecontrol studies, and cross-sectional studies will also be considered. Types of participants This review will consider studies that include adults who have a confirmed diagnosis of schizophrenia receiving medication treatment (typical or atypical antipsychotics) from any health care settings (inpatient or outpatient). Types of interventions This review will include studies that investigate the impact of antipsychotics side effects using standardised instruments (both self-rated and clinician-rated instruments), such as the Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS) or the Udvalg for Kliniske Undersøgelser (UKU) Side Effect Rating Scale. 3
4 Types of outcome measures / anticipated outcomes This review will include studies that quantitatively measure attitudes toward medication using standardised scales, such as the Drug Attitude Inventory (DAI). Attitudes toward medication refer to the patients perception towards different aspects of medication, including, but not limited to medication-taking, medication effects, and/or medication side effects. Exclusion criteria This review will exclude studies that involve: a. Qualitative data analyses as they do not represent the magnitude of the relationship between independent on dependent variables in measureable terms (e.g. correlation or regression coefficients); b. Patients aged less than 18 and more than 65 years old; c. Collecting data without using standardized instruments; and d. Collecting data using standardized instruments that focus on a single aspect of medication side effects (such as weight gain only). Search Strategy for Identification of Studies Prior to commencing this review, a preliminary search of the Joanna-Briggs Institute (JBI) Library of Systematic Reviews and the Cochrane Database of Systematic Reviews was conducted, and no activity of the review topic has been identified. The search strategy aims to find published studies and papers. A three-step search strategy will be utilised in each component of this review. An initial limited search of MEDLINE and the Cumulative Index of Nursing and Allied Health Literature (CINAHL) was undertaken with the search terms antipsychotic, side effect, attitude and schizophrenia used singly or in combination, followed by an analysis of the text words contained in the title and abstract, and of the index terms used to describe the article. The identified keywords and index terms are: Antipsychotic*, neuroleptic*; Side effect*, adverse effect*, adverse drug event*, adverse drug reaction*; Attitude*, subjective response*; Schizophren* A second search using all identified keywords and index terms will be undertaken, and it will extend to the following databases: MEDLINE CINAHL PsycINFO Scopus ScienceDirect Web of Science (Science Citation Index Expanded, Social Science Citation Index, Arts & Humanities Citation Index) 4
5 Search terms will be modified depending on the format used in each database, and the use of database-specific headings will be included where available (e.g. MeSH headings in MEDLINE). The search will be limited to studies in English language and those published between the years 1990 to The search strategy (Appendix I) will cover search fields limited to title, abstract and keywords. Thirdly, the reference list of all identified reports and articles will be searched for additional studies. All studies identified during these searches will be assessed by two independent reviewers for relevance based on the title and abstract. For studies that meet the inclusion criteria or those with inconclusive titles and abstracts, the full text will be retrieved for further assessment against the inclusion criteria to determine their relevance to the review objective. The decision to consider the study for inclusion in the review will then be undertaken by the two reviewers. All references will be entered into the bibliographic software package Endnote. Methods of Review Assessment of Methodological Quality Studies selected for retrieval will be assessed by the two reviewers for methodological quality prior to inclusion in the review using the JBI Critical Appraisal Checklist for Cohort/Case Control appraisal (Appendix II) and the JBI Critical Appraisal Checklist for Descriptive/Case series studies (Appendix III). Any disagreements that arise between the reviewers will be resolved through discussion with a third reviewer. Data Extraction Data will be extracted from studies included in the review using the JBI Data Extraction Form for Comparative Cohort/Case Control studies (Appendix IV) and the JBI Data Extraction Form for Descriptive/Case series studies (Appendix V). Any disagreements that arise between the reviewers will be resolved through discussion with a third reviewer. Data Synthesis Where possible, quantitative research study results will be pooled in statistical meta-analysis using the JBI Meta Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI). All results will be double entered. Odds ratio (for categorical data) and weighted mean differences (for continuous data) and their 95% confidence intervals will be calculated for analysis. Heterogeneity will be assessed using the standard Chi-square. Where statistical pooling is not possible, the findings will be presented in narrative form. Conflict of Interest There are no conflicts of interest regarding this systematic review. 5
6 References 1. Kua E. H., Tan C. H., Ko S. M., & Fones, C. (2004). Psychiatry for Doctors. (3 rd Ed.). Singapore: Armour Publishing. 2. Hofer A, Kemmler G, Eder U, Honeder M, Hummer M, Fleischhacker WW. Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia. J Clin Psychiatry. 2002;63(1): Morrison P, Gaskill D, Meehan T, Lunney P, Lawrence G, Collings P. The use of the Liverpool University neuroleptic side effect rating scale (LUNSERS) in clinical practice. Aust N Z J Ment Health Nurs. 2000;9(4): Cabeza IG, Amador MS, Lopez CA, de Chavez MG. Subjective response to antipsychotics in schizophrenic patients: clinical implications and related factors. Schizophr Res. 2000;41(2): Lambert M, Conus P, Eide P et al. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry. 2004;19(7): Gervin M, Browne S, Garavan J, Roe M, Larkin C, O'Callaghan E. Dysphoric subjective response to neuroleptics in schizophrenia: relationship to extrapyramidal side effects and symptomatology. Eur Psychiatry. 1999;14(7): Rossler W, Salize HJ, Riecher-Rossler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 2005;15(4): Day JC, Wood G, Dewey M, Bentall RP. A self-rating scale for measuring neuroleptic side effects: validation in a group of schizophrenic patients. Br J Psychiatry. 1995;166(5): Awad AG. Subjective response to neuroleptics in schizophrenia. Schizophr Bull. 1993;19(3): McCann TV, Clark E, Lu S. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia. J Adv Nurs. 2009;65(3): Fleischhacker WW, Oehl MA, Hummer M. Factors influencing compliance in schizophrenia patients. J Clin Psychiatry. 2003;64(Suppl 16): Eaddy M, Grogg A, Locklear J. Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population. Clin Ther. 2005;27(2): Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull. 1991;17(2): Lieberman JA, Sheitman B, Chakos M, et al. The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective. J Clin Psychopharmacol. 1998;18(2 suppl 1):20S-24S. 15. Sim E. Predicting outpatient's attitude of compliance on medication in a psychiatric setting. Singapore Nurs J. 2006;33(2): Kemp R, David A. Psychological predictors of insight and compliance in psychotic patients. Br J Psychiatry. 1996;169: Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10): Oehl M, Hummer M, Fleishhacker WW. Compliance with antipsychotic treatment. Acta Psychiatr Scand. 2000;102(suppl 407): Hofer A, Rettenbacher MA, Edlinger M, Kemmler G, Widschwendter CG, Fleischhacker WW. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia. Acta Psychiatr Scand. 2007;116(5):
7 Appendix I Search Strategy MEDLINE (with MeSH Headings) CINAHL (with CINAHL Headings) PsycINFO (with Subject Headings) Scopus ScienceDirect Web of Science 1. (antipsychotic* OR neuroleptic* OR "Antipsychotic Agents"[Mesh]) adverse drug reaction* OR "Drug Toxicity"[Mesh]) 3. (attitude* OR subjective response* ) 4. (schizophren* OR "Schizophrenia"[Mesh]) 1. (antipsychotic* OR neuroleptic* OR MH "Antipsychotic Agents+") adverse drug reaction* OR MH "Medication Side Effects (Saba CCC)" OR MH "Adverse Drug Event") 3. (attitude* OR subjective response* ) 4. (schizophren* OR MH "Schizophrenia") 1. (antipsychotic* OR neuroleptic* OR exp Neuroleptic Drugs /) adverse drug reaction* OR Side Effects (Drug)"/) 3. (attitude* OR Drug Usage Attitudes / OR subjective response* ) 4. (schizophren* OR exp Schizophrenia/) 1. (antipsychotic* OR neuroleptic*) adverse drug reaction* ) 3. (attitude* OR subjective response* ) 4. (schizophren*) 1. (antipsychotic* OR neuroleptic*) adverse drug reaction* ) 3. (attitude* OR subjective response* ) 4. (schizophren*) 1. (antipsychotic* OR neuroleptic*) adverse drug reaction* ) 3. (attitude* OR subjective response* ) 4. (schizophren*) 7
8 Appendix II JBI Critical Appraisal Checklist for Cohort/Case Control appraisal Appendix III JBI Critical Appraisal Checklist for Descriptive/Case series studies 8
9 Appendix IV JBI Data Extraction Form for Comparative Cohort/Case Control studies 9
10 Appendix V JBI Data Extraction Form for Descriptive/Case series studies 10
MINDFULNESS-BASED INTERVENTIONS IN EPILEPSY
03 March 2016; v.1 MINDFULNESS-BASED INTERVENTIONS IN EPILEPSY AIM This review aimed to evaluate the effectiveness of mindfulness as a therapeutic intervention for people with epilepsy. METHODS Criteria
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Effectiveness of progressive muscle relaxation training for adults diagnosed with schizophrenia: a systematic review protocol Carlos Melo-Dias,
More informationWALID SARHAN F.R.C.Psych. Consultant psychiatrist AMMAN-JORDAN
WALID SARHAN F.R.C.Psych. Consultant psychiatrist AMMAN-JORDAN Compliance Definition: The extent to which a person s behaviour (in terms of taking medications, following diets or executing lifestyle changes)
More informationReligious Beliefs and Their Relevance for Adherence to Treatment in Mental Illness: A Review
Religious Beliefs and Their Relevance for Adherence to Treatment in Mental Illness: A Review Pawel Zagozdzon, Magdalena Wrotkowska Department of Hygiene and Epidemiology Medical University of Gdansk 1
More informationJBI Database of Systematic Reviews & Implementation Reports 2014;12(2)
The effectiveness of reducing dietary sodium intake versus normal dietary sodium intake in patients with heart failure on reducing readmission rate: a systematic review protocol Palle Larsen 1,4 Preben
More informationProtocol Sistematic Review
Master in Evidence-Based Practice e Metodologia della Ricerca Clinico-assistenziale Centro Studi EBN Azienda Ospedaliero - Universitaria di Bologna Policlinico S. Orsola - Malpighi Direttore del corso:
More informationCondensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia
Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.
More informationNeuRA Treatment adherence April 2016
Introduction Non-adherence to maintenance treatments, for example antipsychotic medication, is a widespread issue that plagues clinical management for schizophrenia. It reduces the success of the treatment
More informationResults. NeuRA Family relationships May 2017
Introduction Familial expressed emotion involving hostility, emotional over-involvement, and critical comments has been associated with increased psychotic relapse in people with schizophrenia, so these
More informationParticipant views and experiences of participating in HIV research in sub-saharan Africa: a qualitative systematic review protocol
Participant views and experiences of participating in HIV research in sub-saharan Africa: a qualitative systematic review protocol Sylvia Nalubega, RN, BSc, MSc 1 Catrin Evans, RN, BSc, MA, PhD 1 1. The
More informationA comparison of treatment options for management of End Stage Kidney Disease in elderly patients: A systematic review protocol
A comparison of treatment options for management of End Stage Kidney Disease in elderly patients: A systematic review protocol Leanne Brown Master of Nursing Science (Nurse Practitioner) 1 Glenn Gardner
More informationNeuRA Decision making April 2016
Introduction requires an individual to use their knowledge and experience of a context in order to choose a course of action 1. A person s ability to autonomously make decisions is referred to as their
More informationNeuRA Schizophrenia diagnosis May 2017
Introduction Diagnostic scales are widely used within clinical practice and research settings to ensure consistency of illness ratings. These scales have been extensively validated and provide a set of
More informationResults. NeuRA Treatments for dual diagnosis August 2016
Introduction Many treatments have been targeted to improving symptom severity for people suffering schizophrenia in combination with substance use problems. Studies of dual diagnosis often investigate
More informationAnimal-assisted therapy
Introduction Animal-assisted interventions use trained animals to help improve physical, mental and social functions in people with schizophrenia. It is a goal-directed intervention in which an animal
More informationThe effects of cognitive behaviour therapy for major depression in older adults
The effects of cognitive behaviour therapy for major depression in older adults Submitted by Rasika Sirilal Jayasekara RN, BA (Sri Lanka), BScN (Hons) (Sri Lanka), PG Dip Ed (Sri Lanka), MNSc (Adelaide),
More informationResults. NeuRA Forensic settings April 2016
Introduction Prevalence quantifies the proportion of individuals in a population who have a disease during a specific time period. Many studies have reported a high prevalence of various health problems,
More informationResults. NeuRA Mindfulness and acceptance therapies August 2018
Introduction involve intentional and non-judgmental focus of one's attention on emotions, thoughts and sensations that are occurring in the present moment. The aim is to open awareness to present experiences,
More informationThe objective of this systematic review is to assess the impact of migration on the risk of developing gastric cancer.
Review title The effect of migration on gastric cancer risk: A systematic review protocol Reviewers Haejin In, MD, MBA, MPH 1 Marisa Langdon-Embry, MS 2 1 Albert Einstein College of Medicine, haejin.in@einstein.yu.edu
More informationMETHODS RESULTS. Supported by funding from Ortho-McNeil Janssen Scientific Affairs, LLC
PREDICTORS OF MEDICATION ADHERENCE AMONG PATIENTS WITH SCHIZOPHRENIC DISORDERS TREATED WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS IN A LARGE STATE MEDICAID PROGRAM S.P. Lee 1 ; K. Lang 2 ; J. Jackel 2 ;
More informationNeuRA Obsessive-compulsive disorders October 2017
Introduction (OCDs) involve persistent and intrusive thoughts (obsessions) and repetitive actions (compulsions). The DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) defines
More informationProblem solving therapy
Introduction People with severe mental illnesses such as schizophrenia may show impairments in problem-solving ability. Remediation interventions such as problem solving skills training can help people
More informationResults. NeuRA Worldwide incidence April 2016
Introduction The incidence of schizophrenia refers to how many new cases there are per population in a specified time period. It is different from prevalence, which refers to how many existing cases there
More informationResults. NeuRA Essential fatty acids August 2016
Introduction Alternative treatments are investigated as a possible replacement for antipsychotic medication, which can be associated with severe side effects. Alternative therapies may have less debilitating
More informationResults. NeuRA Treatments for internalised stigma December 2017
Introduction Internalised stigma occurs within an individual, such that a person s attitude may reinforce a negative self-perception of mental disorders, resulting in reduced sense of selfworth, anticipation
More informationResults. NeuRA Hypnosis June 2016
Introduction may be experienced as an altered state of consciousness or as a state of relaxation. There is no agreed framework for administering hypnosis, but the procedure often involves induction (such
More informationTraumatic brain injury
Introduction It is well established that traumatic brain injury increases the risk for a wide range of neuropsychiatric disturbances, however there is little consensus on whether it is a risk factor for
More informationOutcomes assessed in the review
The effectiveness of mechanical compression devices in attaining hemostasis after removal of a femoral sheath following femoral artery cannulation for cardiac interventional procedures Jones T Authors'
More informationClass Update: Oral Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationIs Lurasidone more safe and effective in the treatment ofschizoaffective disorder and schizophrenia than other commonanti-psychotic medications?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2015 Is Lurasidone more safe and effective
More informationNeuRA Schizophrenia diagnosis June 2017
Introduction Diagnostic scales are widely used within clinical practice and research settings to ensure consistency of illness ratings. These scales have been extensively validated and provide a set of
More informationNeuRA Sleep disturbance April 2016
Introduction People with schizophrenia may show disturbances in the amount, or the quality of sleep they generally receive. Typically sleep follows a characteristic pattern of four stages, where stage
More information8/22/2016. Contemporary Psychiatric-Mental Health Nursing Third Edition. Features of Schizophrenia. Features of Schizophrenia (cont'd)
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 16 Schizophrenia Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties, but can be as
More informationMethod. NeuRA Negative symptoms April 2016
Introduction The negative symptoms of schizophrenia refer to an absence of normal functions. This may include (but is not limited to); blunted affect, which is a scarcity of facial expressions of emotion,
More informationRisk factors for incident delirium in acute medical in-patients. A systematic review
Risk factors for incident delirium in acute medical in-patients. A systematic review Reviewers Emily Cull RN, BN(Hons) 1 Bridie Kent PhD, BSc(Hons), RN 2 Dr Nicole M. Phillips DipAppSc(Nsg), BN, GDipAdvNsg(Educ),
More informationCENTRE CONDUCTING THE REVIEW. New South Wales Centre for Evidence Based Health Care
Factorsdeterminingdiabetescareoutcomesinpatientswith type1diabetesaftertransitionfrompaediatrictoadult healthcare:asystematicreview Protocol CENTRECONDUCTINGTHEREVIEW New South Wales Centre for Evidence
More informationFactors affecting adherence in patients with schizophrenia
International Journal of Advances in Medicine Siddiqui MA et al. Int J Adv Med. 2016 Feb;3(1):25-32 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20151483
More informationEvidence that the Two-Way Communication Checklist identifies patient doctor needs discordance resulting in better 6-month outcome
Acta Psychiatr Scand 2008: 118: 322 326 All rights reserved DOI: 10.1111/j.1600-0447.2008.01228.x Copyright Ó 2008 The Authors Journal Compilation Ó 2008 Blackwell Munksgaard ACTA PSYCHIATRICA SCANDINAVICA
More informationThe effect of insulin therapy algorithms on blood glucose levels in patients following cardiac surgery: A systematic review protocol
The effect of insulin therapy algorithms on blood glucose levels in patients following cardiac surgery: A systematic review protocol Megan Higgs, BN, MN, PhD Candidate 1,3 Ritin Fernandez, BSc (Nursing),
More informationContemporary Psychiatric-Mental Health Nursing. Features of Schizophrenia. Features of Schizophrenia - continued
Contemporary Psychiatric-Mental Health Nursing Chapter 16 Schizophrenia and Other Psychotic Disorders Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties,
More informationDistraction techniques
Introduction are a form of coping skills enhancement, taught during cognitive behavioural therapy. These techniques are used to distract and draw attention away from the auditory symptoms of schizophrenia,
More informationOlder persons perceptions and experiences of community palliative care: a systematic review of qualitative evidence protocol
Older persons perceptions and experiences of community palliative care: a systematic review of qualitative evidence protocol Antoinette H. Cotton Jan Maree Sayers New South Wales Centre for Evidenced Based
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Psychosis and schizophrenia in adults: treatment and management Quality standard title:
More informationEffect of peak inspiratory pressure on the development. of postoperative pulmonary complications.
Effect of peak inspiratory pressure on the development of postoperative pulmonary complications in mechanically ventilated adult surgical patients: a systematic review protocol Chelsa Wamsley Donald Missel
More informationSupplementary Online Content
Supplementary Online Content Subotnik KL, Casaus LR, Ventura J, et al. Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia:
More informationPsychotic illnesses and young women s experiences: a systematic review protocol of qualitative research
Psychotic illnesses and young women s experiences: a systematic review protocol of qualitative research Wanda M Chernomas 1 Kendra L Rieger 2 Jane V Karpa 3 Diana E Clarke 4 Shelley Marchinko 1 Lisa Demczuk
More informationQuality of life in people with vitiligo: a systematic review and meta-analysis
Quality of life in people with vitiligo: a systematic review and meta-analysis B Morrison 1, E Burden-Teh 2, JM Batchelor 2, E Mead 2, D Grindlay 2, S Ratib 2 Affiliations 1 University of Nottingham, Medical
More informationTreatment of Schizophrenia
Treatment of Schizophrenia Conduct comprehensive assessment and use measurement-based care as found in the Principles of Practice (review pages 4-7). Most importantly assess social support system (housing,
More informationMethod. NeuRA Paliperidone August 2016
Introduction Second generation antipsychotics (sometimes referred to as atypical antipsychotics) are a newer class of antipsychotic medication than first generation typical antipsychotics. Second generation
More informationOutcomes in Schizophrenia Systematic Reviews
Outcomes in Schizophrenia Systematic Reviews Jouko Miettunen Professor of Clinical Epidemiology Center for Life Course Epidemiology and Systems Medicine, University of Oulu, Finland This project is co-funded
More informationMethod. NeuRA Biofeedback May 2016
Introduction is a technique in which information about the person s body is fed back to the person so that they may be trained to alter the body s conditions. Physical therapists use biofeedback to help
More informationThe Effects of Macronutrient Intake on the Risk of Developing Type 2 Diabetes: A Systematic Review
Review Title The Effects of Macronutrient Intake on the Risk of Developing Type 2 Diabetes: A Systematic Review Centre Conducting Review The University of Newcastle Evidence Based Health Care Group: Joanna
More informationThe effects of binaural beat technology on physiological and psychological outcomes in adults: a systematic review protocol
The effects of binaural beat technology on physiological and psychological outcomes in adults: a systematic review protocol Yi-Tzu Sun, RN, MSN 1,2,3 Huei-Chuan Sung, RN, PhD 3,4 1. PhD candidate, Institute
More informationResults. NeuRA Motor dysfunction April 2016
Introduction Subtle deviations in various developmental trajectories during childhood and adolescence may foreshadow the later development of schizophrenia. Studies exploring these deviations (antecedents)
More informationComparison of pre-treatment clinical characteristics and post-treatment outcomes of patients treated with Clozapine and long acting antipsychotics
Research Comparison of pre-treatment clinical characteristics and post-treatment outcomes of patients treated with Dante M Durand,1, Phillip Harvey 1,2, Ricardo Cáceda 3 ABSTRACT Introduction: Clozapine
More informationSystematic reviews and meta-analyses of observational studies (MOOSE): Checklist.
Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:
More informationResults. NeuRA Herbal medicines August 2016
Introduction have been suggested as a potential alternative treatment which may positively contribute to the treatment of schizophrenia. Herbal therapies can include traditional Chinese medicines and Indian
More informationProtocol for literature review on psychotropic drug use in children Revised 2016/04/30
Protocol for literature review on psychotropic drug use in children Revised 2016/04/30 This protocol is designed to answer the following research questions: 1. What recent studies have examined the use
More informationCochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library)
A systematic review of smoking cessation and relapse prevention interventions in parents of babies admitted to a neonatal unit (after delivery) Divya Nelson, Sarah Gentry, Caitlin Notley, Henry White,
More information2. How do different moderators (in particular, modality and orientation) affect the results of psychosocial treatment?
Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies Mojtabai R, Nicholson R A, Carpenter B N Authors' objectives To investigate the role
More informationMethod. NeuRA Schizophrenia and bipolar disorder April 2016
Introduction Schizophrenia is characterised by positive, negative and disorganised symptoms. Positive symptoms refer to experiences additional to what would be considered normal experience, such as hallucinations
More informationThe treatment of postnatal depression: a comprehensive literature review Boath E, Henshaw C
The treatment of postnatal depression: a comprehensive literature review Boath E, Henshaw C Authors' objectives To evalute treatments of postnatal depression. Searching MEDLINE, PsycLIT, Sociofile, CINAHL
More informationTranscranial Direct-Current Stimulation
Introduction (tdcs) is a non-invasive form of brain stimulation similar to transcranial magnetic stimulation, but instead of using magnets, it uses a lowintensity, constant current applied through scalp
More informationA Case of Hyper Sexuality Probably Associated with Clozapine
Complicated Case Histories Key Words: atypical antipsychotic, adverse drug reaction, hypersexuality A Case of Hyper Sexuality Probably Associated with Clozapine By Sereen Rose Thomson, Navin Patil, Balaji
More informationNovember 2014 MRC2.CORP.X.00004
This program is paid for by Otsuka America Pharmaceutical, Inc. and Lundbeck, LLC. The speaker is a paid consultant of Otsuka America Pharmaceutical, Inc. advice or professional diagnosis. Users seeking
More informationCOPING STRATEGIES OF THE RELATIVES OF SCHIZOPHRENIC PATIENTS
Indian Journal of Psychiatry, 2002,44(1 ),9-13 COPING STRATEGIES OF THE RELATIVES OF SCHIZOPHRENIC PATIENTS R.CHANDRASEKARAN, SIVAPRAKASH B.& S.R JAYESTRI ABSTRACT Families caring for a member with a chronic
More informationJBI Library of Systematic Reviews JBL ; 10 (58)
The effectiveness of group visits for patients with heart failure on knowledge, quality of life, self-care, and readmissions: a systematic review protocol Jason T Slyer, DNP, RN, FNP-BC, CHFN 1,2 Lucille
More informationStructural barriers to highly active antiretroviral therapy (HAART) adherence: a systematic review protocol
Structural barriers to highly active antiretroviral therapy (HAART) adherence: a systematic review protocol Garumma Tolu Feyissa MPH 1,5 Aderajew Nigussie MPH 2,5 Tariku Dejene Demissie MSc 3,5 Mirkuzie
More informationDANIEL MOLLOY, MD MENTOR: JAMES STEPHEN, MD
Blood Glucose Control in a Schizophrenic Population in an Outpatient Setting DANIEL MOLLOY, MD MENTOR: JAMES STEPHEN, MD Schizophrenia Complex psychiatric disorder with many medical and psychosocial complications.
More informationEffect of Instructional Module on Drug Adherence in Terms of Attitude among Patients with Schizophrenia
Original Article NUJHS Vol. 6, No.1, March 2016, ISSN 2249-7110 Effect of Instructional Module on Drug Adherence in Terms of Attitude among Patients with Schizophrenia 1 S. Mary Metilda, S. Santhi² & G.
More informationNeuRA Schizophrenia diagnosis October 2017
Introduction Diagnostic scales are widely used within clinical practice and research settings to ensure consistency of illness ratings. These scales have been extensively validated and provide a set of
More informationKeywords: Internet, obesity, web, weight loss. obesity reviews (2010) 11,
obesity reviews doi: 10.1111/j.1467-789X.2009.00646.x Obesity Management Effectiveness of web-based interventions in achieving weight loss and weight loss maintenance in overweight and obese adults: a
More informationAT RISK MENTAL STATES IN PSYCHOSIS AND SCHIZOPHRENIA IN CHILDREN AND YOUNG PEOPLE
AT RISK MENTAL STATES IN PSYCHOSIS AND SCHIZOPHRENIA IN CHILDREN AND YOUNG PEOPLE Topic AT RISK MENTAL STATES IN PSYCHOSIS AND SCHIZOPHRENIA IN CHILDREN AND YOUNG PEOPLE Scope 4.3.1 (a) Review question(s)
More informationEarly Stages of Psychosis. Learning Objectives
Early Stages of Psychosis Stephan Heckers, MD MSc Department of Psychiatry and Behavioral Sciences Vanderbilt University Learning Objectives Summarize the five domains of psychosis Describe how psychotic
More informationMethod. NeuRA Positive symptoms June 2017
Introduction (or reality distortion symptoms) of schizophrenia are a welldocumented feature of the disorder and are arguably the most recognisable and conspicuous symptoms of the illness. Positive symptoms
More informationIntroduction. J Mwanza 1, R Paul 1, JM Ncheka 1, P Petlovani 1. 1.University of Zambia School of Medicine, Department of Psychiatry
RESEARCH ARTICLE Appropriateness of antipsychotic drugs prescribed for First episode psychosis by clinicians at Chainama Hills college hospital in Lusaka J Mwanza 1, R Paul 1, JM Ncheka 1, P Petlovani
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Psychosis and schizophrenia in children and young people: recognition and management 1.1 Short title Psychosis and schizophrenia
More informationSchizophrenia: New Concepts for Therapeutic Discovery
Schizophrenia: New Concepts for Therapeutic Discovery William T. Carpenter, M.D. Professor of Psychiatry and Pharmacology University of Maryland School of Medicine Department of Psychiatry Maryland Psychiatric
More informationPreventing relapse in schizophrenia: a real priority or only a tick-box exercise? John Donoghue Liverpool
Preventing relapse in schizophrenia: a real priority or only a tick-box exercise? John Donoghue Liverpool L imagination est plus important que le savoir Albert Einstein Copyright John Donoghue 2013 These
More informationI received help from Bosch Health Care
John Kasckow, MD, PhD VA Pittsburgh Health Care System Western Psychiatric Institute and Clinic, UPMC VA Pittsburgh Health Care System I received help from Bosch Health Care 1 Diagnoses of Interest Early
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Search terms*
Supplementary Figure S1. Search terms* *mh = exploded MeSH: Medical subject heading (Medline medical index term); tw = text word; pt = publication type; the asterisk (*) stands for any character(s) #1:
More informationThe detection and management of pain in patients with dementia in acute care settings: development of a decision tool: Research protocol.
The detection and management of pain in patients with dementia in acute care settings: development of a decision tool: Research protocol. Aims and Objectives of the overall study The aim of this study
More informationSYSTEMATIC REVIEW PROTOCOL
SYSTEMATIC REVIEW PROTOCOL Title of Systematic Review Protocol A systematic review of differences between brain temperature and core body temperature in adult patients with severe traumatic brain injury
More informationA Collaborative Approach To Care Coordination For Patients With Schizophrenia: Perspectives From Nursing & Social Work
A Collaborative Approach To Care Coordination For Patients With Schizophrenia: Perspectives From Nursing & Social Work Brooke Kempf PMHNP Psychiatric Mental Health Nurse Practitioner Hamilton Center, Inc.
More informationInformation about the Critically Appraised Topic (CAT) Series
Information about the Critically Appraised Topic (CAT) Series The objective of the Doctor of Nursing Practice (DNP) program at George Mason University is to prepare graduates for the highest level of nursing
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews A systematic review of behaviour change interventions targeting physical activity, exercise and HbA1c in adults with type 2 diabetes Leah
More informationTable 2. Distribution of Normalized Inverse Probability of Treatment Weights. Healthcare costs (US $2012) Notes:
228 COMPARISON OF HEALTHCARE RESOURCE UTILIZATION AND MEDICAID SPENDING AMONG PATIENTS WITH SCHIZOPHRENIA TREATED WITH ONCE MONTHLY PALIPERIDONE PALMITATE OR ORAL ATYPICAL ANTIPSYCHOTICS USING THE INVERSE
More informationAbbreviated Class Review: Long-Acting Injectable Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationAbbreviated Class Review: Long-Acting Injectable Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationA Systematic Review of the Efficacy and Clinical Effectiveness of Group Analysis and Analytic/Dynamic Group Psychotherapy
A Systematic Review of the Efficacy and Clinical Effectiveness of Group Analysis and Analytic/Dynamic Group Psychotherapy Executive summary Aims of the review The main aim of the review was to assess the
More informationThe effectiveness of peer support interventions for community-dwelling adults with chronic non-cancer pain: a systematic review protocol
The effectiveness of peer support interventions for community-dwelling adults with chronic non-cancer pain: a systematic review protocol Kay Cooper, PhD, MSc, BSc 1 Sylvia Wilcock, PhD 1 1. The Scottish
More information9/3/2014. Contemporary Psychiatric-Mental Health Nursing Third Edition. Features of Schizophrenia. Features of Schizophrenia (cont'd)
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 16 Schizophrenia Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties, but can be as
More informationFidelity and Outcomes in Community Care
Faculty Disclosure Alex Kopelowicz, MD Dr. Kopelowicz has listed no financial interest/arrangement that would be considered a conflict of interest. Fidelity and Outcomes in Community Care Alex Kopelowicz,
More informationIndividualising antipsychotic treatment for patients with schizophrenia John Donoghue Liverpool
Copyright John Donoghue 2015 Individualising antipsychotic treatment for patients with schizophrenia John Donoghue Liverpool Copyright John Donoghue 2015 QUESTIONS Why do outcomes in schizophrenia remain
More informationNoncompliance with Treatment among Psychiatric Patients in Kuwait
Original Paper Med Principles Pract 1998;7:28 32 Received: December 12, 1996 Revised: March 22, 1997 Abdullahi A. Fido Abdulrazik M. Husseini Faculty of Medicine, Kuwait University, Kuwait Noncompliance
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Preventing falls and associated mortality in older people: an umbrella review of systematic reviews Mukesh Dherani, Stefanie Buckner, Daniel
More informationAdult women s experiences of urinary incontinence: a systematic review of qualitative evidence protocol
Adult women s experiences of urinary incontinence: a systematic review of qualitative evidence protocol Adilson Mendes 1 Luiza Hoga 1 Bruna Gonçalves 1 Pamela Silva 1 Priscilla Pereira 1 1. School of Nursing,
More informationChapter 17. Psychoses. Classifications of Psychoses. Schizophrenia. Factors Attributed to Development of Psychoses
Chapter 17 Psychoses Drugs for Psychoses Delusions Hallucinations Illusions Paranoia Upper Saddle River, New Jersey 07458 All rights reserved. Classifications of Psychoses Acute episode Chronic episode
More informationChapter 12. Schizophrenia and Other Psychotic Disorders. PSY 440: Abnormal Psychology. Rick Grieve Western Kentucky University
Chapter 12 Schizophrenia and Other Psychotic Disorders PSY 440: Abnormal Psychology Rick Grieve Western Kentucky University psychotic disorders disorders so severe that the person has essentially lost
More informationClinical Guidelines for the Pharmacologic Treatment of Schizophrenia
Clinical Guidelines for the Pharmacologic Treatment of Community Behavioral Health (CBH) is committed to working with our provider partners to continuously improve the quality of behavioral healthcare
More information